Trial intelligence / Profile preview

Sequential vs Traditional HCG and FSH Therapy for Hypogonadotropic Hypogonadism

NCT01403532Phase 4Completed

Sponsor
Shanghai Jiao Tong University School of Medicine
Start
Sep 2009
Primary completion
Dec 2012
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of follitropin in hypogonadotropic hypogonadism (HH), Kallmann syndrome (KS), sponsored by Shanghai Jiao Tong University School of Medicine. Started Sep 2009; status: completed.

02

Drugs

follitropin
03

Conditions

hypogonadotropic hypogonadism (HH)Kallmann syndrome (KS)

Beyond the preview

Go deeper on NCT01403532.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01403532.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call